Trials / Conditions / Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

62 registered clinical trials studyying Neonatal Abstinence Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for NCT04783558	Washington State University	N/A
Recruiting	An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT) NCT06576323	University of Pennsylvania	N/A
Enrolling By Invitation	Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Proces NCT06303986	Rekovar Inc.	—
Recruiting	The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program NCT05226624	University of Alberta	N/A
Active Not Recruiting	Neurostimulation to Improve NOWS Outcomes NCT05129020	Spark Biomedical, Inc.	N/A
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-stud NCT03911739	T. John Winhusen, PhD	—
Unknown	Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units NCT04983563	University Hospital, Caen	N/A
Active Not Recruiting	A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants NCT04419857	Yale University	N/A
Unknown	Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine NCT04611659	Meharry Medical College	N/A
Completed	Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human NCT04508348	The University of Texas Health Science Center at San Antonio	N/A
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers NCT03918850	T. John Winhusen, PhD	Phase 3
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study NCT03911466	T. John Winhusen, PhD	—
Completed	Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome NCT04298853	Indiana University	Phase 4
Completed	tAN to Mitigate Withdrawal Behaviors in Neonates NCT04588519	Spark Biomedical, Inc.	N/A
Recruiting	MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome NCT05937594	Milton S. Hershey Medical Center	—
Completed	Assessing the Effects of Auricular Acupressure on Newborns With NAS NCT03890562	Virginia Commonwealth University	N/A
Completed	Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS) NCT03973801	Vanderbilt University Medical Center	N/A
Completed	Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions NCT04049799	University of Vermont	—
Terminated	Interventions to Help Infants Recover in the Hospital NCT03881553	Elisabeth Salisbury, PhD	N/A
Completed	Sound Processing Changes in Babies With Opioid Exposure NCT03567603	University of Rochester	—
Completed	The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky NCT03725332	Wendy F Hansen	N/A
Unknown	Actigraphy and Neonatal Abstinence Syndrome NCT03977545	University Hospital, Caen	N/A
Completed	The Effect of Music Therapy on Newborns NCT03987165	Tulane University	N/A
Completed	MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study NCT03718104	Boston Medical Center	—
Completed	Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome NCT03670160	University of Tennessee Medical Center	Phase 2
Completed	Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure NCT03608696	Thomas Jefferson University	Phase 1 / Phase 2
Terminated	Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome NCT03762317	Hennepin County Medical Center, Minneapolis	Phase 4
Active Not Recruiting	Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy NCT03092011	The Cooper Health System	Phase 4
Completed	Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain NCT03396588	Henrietta Bada	Phase 3
Completed	Weighted Blankets With Infants With NAS NCT03113656	TriHealth Inc.	N/A
Terminated	Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk NCT03246243	Boston Children's Hospital	—
Completed	Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome NCT02801331	Elisabeth B Salisbury	N/A
Terminated	Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence S NCT03134703	Johns Hopkins All Children's Hospital	Phase 2
Completed	Buprenorphine Dose Adjustments and Gestational Age NCT03028883	St. Louis University	—
Completed	Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome NCT02851303	University of New Mexico	Phase 4
Completed	Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome NCT02872077	University of South Florida	N/A
Completed	Conflict Between Maternal Autonomy and Child Health in Substance-use NCT02797990	London School of Hygiene and Tropical Medicine	—
Completed	The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels NCT03097484	John M. Daniel	Phase 3
Completed	Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women NCT01965704	Stanford University	Phase 2
Completed	Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome NCT03549936	MetroHealth Medical Center	N/A
Completed	Donor Human Milk in Neonatal Abstinence Syndrome NCT02182973	Neolac Inc dba Medolac Laboratories	—
Completed	Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies NCT02062151	University of South Florida	N/A
Completed	Improving Outcomes in Neonatal Abstinence Syndrome NCT01958476	Tufts Medical Center	Phase 3
Completed	RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure NCT02334111	Boston Medical Center	N/A
Completed	Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers NCT01889121	Dr. Henry Akinbi	—
Completed	The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome NCT01754324	Children's Hospital Medical Center, Cincinnati	—
Completed	Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) NCT01708707	Pediatrix	Phase 2
Completed	Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepin NCT01671410	Thomas Jefferson University	Phase 1
Completed	Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome NCT03334981	University Hospital, Caen	—
Completed	Fetal and Infant Effects of Maternal Buprenorphine Treatment NCT01561079	Johns Hopkins University	Phase 2 / Phase 3
Completed	Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome NCT01452789	Thomas Jefferson University	Phase 3
Completed	NAS Treatment - Opiate Versus Non-Opiate NCT01734551	Henrietta Bada	Phase 4
Terminated	Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants NCT01360450	Johns Hopkins University	Phase 2 / Phase 3
Completed	Physiology and Therapeutic Management of Neonatal Abstinence Syndrome NCT02768844	University of Massachusetts, Worcester	N/A
Completed	Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal NCT01804075	Eastern Maine Medical Center	Phase 4
Terminated	Clonidine for Neonatal Abstinence Syndrome Study NCT01175668	Baystate Medical Center	N/A
Completed	RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants NCT02178189	University of Pittsburgh	Phase 2
Completed	Treatment of Neonatal Abstinence Syndrome NCT01723722	Eastern Maine Medical Center	Phase 4
Completed	Vagal Tone and Neonatal Abstinence Syndrome NCT00496951	Johns Hopkins University	—
Completed	Buprenorphine for the Treatment of Neonatal Abstinence Syndrome NCT00521248	Thomas Jefferson University	Phase 1
Completed	Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome NCT00510016	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	How to Treat Opiate Withdrawal in Neonates NCT02810782	University of Zurich	Phase 3